JP2014534227A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014534227A5 JP2014534227A5 JP2014540047A JP2014540047A JP2014534227A5 JP 2014534227 A5 JP2014534227 A5 JP 2014534227A5 JP 2014540047 A JP2014540047 A JP 2014540047A JP 2014540047 A JP2014540047 A JP 2014540047A JP 2014534227 A5 JP2014534227 A5 JP 2014534227A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- moiety
- compound according
- linker
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161553854P | 2011-10-31 | 2011-10-31 | |
| US61/553,854 | 2011-10-31 | ||
| PCT/US2012/062850 WO2013151584A1 (en) | 2011-10-31 | 2012-10-31 | Compound comprising a mao targeting/ seeker moiety for treating human gliomas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014534227A JP2014534227A (ja) | 2014-12-18 |
| JP2014534227A5 true JP2014534227A5 (enExample) | 2015-11-12 |
| JP6118808B2 JP6118808B2 (ja) | 2017-04-19 |
Family
ID=47146760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014540047A Expired - Fee Related JP6118808B2 (ja) | 2011-10-31 | 2012-10-31 | ヒトグリオームを治療するためのｍａｏ標的化／探索部分を含む化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10555936B2 (enExample) |
| EP (2) | EP2804604A1 (enExample) |
| JP (1) | JP6118808B2 (enExample) |
| KR (1) | KR102110794B1 (enExample) |
| CN (1) | CN104136026B (enExample) |
| AU (1) | AU2012376221A1 (enExample) |
| CA (1) | CA2887928A1 (enExample) |
| HK (1) | HK1204547A1 (enExample) |
| WO (1) | WO2013151584A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6118808B2 (ja) | 2011-10-31 | 2017-04-19 | ザ メソジスト ホスピタル リサーチ インスティテュート | ヒトグリオームを治療するためのｍａｏ標的化／探索部分を含む化合物 |
| CN104710433B (zh) * | 2014-01-23 | 2016-08-17 | 南京友怡医药科技有限公司 | 苯丁酸氮芥衍生物、制备方法及应用 |
| WO2015153516A1 (en) * | 2014-04-04 | 2015-10-08 | University Of Florida Research Foundation | Hdac inhibitor compounds and methods of treatment |
| US12245355B2 (en) | 2021-02-19 | 2025-03-04 | Mevion Medical Systems, Inc. | Gantry for a particle therapy system |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4913891A (en) * | 1986-04-17 | 1990-04-03 | The United States Of America As Represented By The United States Department Of Energy | Positron emitter labeled enzyme inhibitors |
| US5466468A (en) | 1990-04-03 | 1995-11-14 | Ciba-Geigy Corporation | Parenterally administrable liposome formulation comprising synthetic lipids |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| WO1994029333A1 (en) * | 1993-06-07 | 1994-12-22 | The Wellcome Foundation Limited | Immunoreactive reagents employing monoamine oxidase |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| US5612329A (en) | 1995-06-05 | 1997-03-18 | University Of Maryland At Baltimore | Diaziridinylpolyamine anti-cancer agents |
| WO1998022110A1 (en) * | 1996-11-20 | 1998-05-28 | Virginia Tech Intellectual Properties, Inc. | Prodrugs for the selective inhibition of monoamine oxidase-b |
| CN1349498A (zh) | 1999-03-03 | 2002-05-15 | 宝洁公司 | 含有链烯基和炔基的金属蛋白酶抑制剂 |
| WO2002038628A2 (en) | 2000-11-07 | 2002-05-16 | Symyx Technologies, Inc. | Substituted pyridyl amine ligands, complexes and catalysts therefrom; processes for producing polyolefins therewith |
| US6946479B2 (en) | 2002-11-09 | 2005-09-20 | The Procter & Gamble Company | N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones |
| US7943586B2 (en) | 2003-06-09 | 2011-05-17 | The Trustees Of The University Of Pennsylvania | Antineoplastic agents targeted via glut transporters |
| WO2005111016A1 (en) * | 2004-05-14 | 2005-11-24 | Pfizer Products Inc. | Pyrimidine derivatives for the treatment of abnormal cell growth |
| US7091205B2 (en) | 2004-10-08 | 2006-08-15 | Yu Show Fu | Use of tetramethylpyrazine in the treatment of brain tumor |
| GB0513297D0 (en) | 2005-06-29 | 2005-08-03 | Glaxo Group Ltd | Novel compounds |
| US20070275944A1 (en) | 2006-04-05 | 2007-11-29 | The Board Of Trustees Operating Michigan State University | Antioxidants and methods of their use |
| AR070317A1 (es) * | 2008-02-06 | 2010-03-31 | Osi Pharm Inc | Furo (3,2-c) piridina y tieno (3,2-c) piridinas |
| CN102015707A (zh) * | 2008-02-29 | 2011-04-13 | 阵列生物制药公司 | Raf抑制剂化合物及其使用方法 |
| EP2141163A1 (de) * | 2008-07-02 | 2010-01-06 | Bayer Schering Pharma AG | Substituierte Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel |
| ES2668775T3 (es) * | 2009-06-10 | 2018-05-22 | Chugai Seiyaku Kabushiki Kaisha | Compuestos tetracíclicos |
| WO2011035332A1 (en) * | 2009-09-21 | 2011-03-24 | Chemocentryx, Inc. | Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators |
| JP6118808B2 (ja) | 2011-10-31 | 2017-04-19 | ザ メソジスト ホスピタル リサーチ インスティテュート | ヒトグリオームを治療するためのｍａｏ標的化／探索部分を含む化合物 |
-
2012
- 2012-10-31 JP JP2014540047A patent/JP6118808B2/ja not_active Expired - Fee Related
- 2012-10-31 AU AU2012376221A patent/AU2012376221A1/en not_active Abandoned
- 2012-10-31 KR KR1020147014835A patent/KR102110794B1/ko not_active Expired - Fee Related
- 2012-10-31 HK HK15103179.0A patent/HK1204547A1/xx unknown
- 2012-10-31 CA CA2887928A patent/CA2887928A1/en not_active Abandoned
- 2012-10-31 CN CN201280064763.1A patent/CN104136026B/zh not_active Expired - Fee Related
- 2012-10-31 EP EP12783818.3A patent/EP2804604A1/en not_active Withdrawn
- 2012-10-31 WO PCT/US2012/062850 patent/WO2013151584A1/en not_active Ceased
- 2012-10-31 EP EP20189611.5A patent/EP3815685A3/en not_active Withdrawn
-
2014
- 2014-04-30 US US14/266,729 patent/US10555936B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102123365B1 (ko) | 항박테리아 치료제 및 예방제 | |
| JP6352244B2 (ja) | 骨格筋疲労に対する耐性を向上させるための方法 | |
| EP2182961B1 (en) | Prevention of gastric ulcery by carbon monoxide | |
| JP6262225B2 (ja) | オキサビシクロヘプタン類、および再灌流障害の治療のためのオキサビシクロヘプタン類 | |
| EA036001B1 (ru) | Комбинация эрлотиниба и ингибитора глутаминазы для лечения рака легких | |
| US20100152121A1 (en) | Iodo-Hexose Compounds Useful to Treat Cancer | |
| TW201244714A (en) | PARP inhibitors for the treatment of CIPN | |
| JP2010523696A (ja) | 脳腫瘍を治療する方法 | |
| US20200179417A1 (en) | Combination chemotherapies | |
| EP3697767A1 (en) | Compounds and methods for treating cancer | |
| RU2011151861A (ru) | Оксазолидинонсодержащие димерные соединения, композиции и способы их получения и использования | |
| EP3011972A1 (en) | Medicinal composition for promoting synthesis of protoporphyrin ix | |
| JP2013504590A (ja) | 非放射性リン脂質化合物、組成物、及び使用方法 | |
| JP2019523783A (ja) | がんの治療に有用なポルフィリン化合物及び組成物 | |
| TW201309298A (zh) | 治療惡性神經膠質瘤之醫藥組合物 | |
| Friedman et al. | Schedule-dependent activity of irinotecan plus BCNU against malignant glioma xenografts | |
| CN104136026B (zh) | 包含mao靶向/探寻器部分的人神经胶质瘤治疗用化合物 | |
| CA3115103A1 (en) | Pi3k inhibitors and uses thereof | |
| AU2017235350B2 (en) | Combination therapy for proliferative diseases | |
| Harasaki et al. | Potential usefulness of radiosensitizers in glioblastoma | |
| US20100087398A1 (en) | Dihydropyridine derivative for treating cancer or a pre-cancerous condition and other conditions | |
| RU2444358C1 (ru) | Антиоксидантная и иммуностимулирующая композиция | |
| RU2639819C2 (ru) | Композиция, ингибирующая теломеразу | |
| JP2019131508A (ja) | ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法 | |
| JP2023505690A5 (enExample) |